Outcomes4Me Secures $21M to Enhance AI-Driven Cancer Care

May 30, 2025
Outcomes4Me has raised $21 million to expand its AI-driven cancer care platform, with new investment from Salica Investments and existing backers like Labcorp Venture Fund.
Outcomes4Me Secures $21M to Enhance AI-Driven Cancer Care

Outcomes4Me has secured $21 million in funding to advance its AI-driven platform for cancer care, announced in a press release. The funding round includes new investor Salica Investments and existing backers such as Labcorp Venture Fund and Sierra Ventures, bringing the company's total capital raised to $38 million.

The Boston-based company aims to use the funds to enhance its platform, which integrates clinical guidelines, genomic insights, and clinical trial matching into a user-friendly interface for cancer patients. Outcomes4Me plans to expand its market reach across various cancer types and geographies, leveraging its proprietary datasets to offer more precise treatment recommendations.

With over 280,000 cancer patients already using its platform, Outcomes4Me is focused on scaling its operations and strengthening collaborations with top-tier health systems and life sciences companies globally. The company is also committed to driving revenue growth through new partnerships and innovative business models.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.